Drug spending is rising sharply, with high-cost GLP-1 medications driving nearly half of the incr | How RxSense helped a health system invest in its own PBM and take control of rising GLP-1 costs.

As medical costs continue to rise, employers are weighing a return to policies that shift additional expense to workers, according to a new survey. | As medical costs continue to…

The Federal Trade Commission may be winding down its ongoing insulin case against the three largest pharmacy benefit managers, as court documents suggest the agency has reached an…

Drug spending is rising sharply, with high-cost GLP-1 medications driving nearly half of the incr | How RxSense helped a health system invest in its own PBM and take control of…